The HER2 signaling network in human heart failure, implication for brest cancer treatment

被引：0
|
作者：
Leszek, P. [1 ]
Stachurska, A. [2 ,3 ]
Kusmierczyk, M. [1 ]
Kolsut, P. [1 ]
Szafron, L. [2 ,3 ]
Jagielska, B. [2 ,3 ]
Rywik, T. [1 ]
机构：
[1] Inst Cardiol, Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6159
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
  • [21] Targeted HER2 Treatment in Advanced Gastric Cancer
    Jorgensen, Jan Trost
    ONCOLOGY, 2010, 78 (01) : 26 - 33
  • [22] Dual inhibition of HER2 in breast cancer treatment
    Gnant, Michael
    Steger, Guenther G.
    LANCET, 2012, 379 (9816): : 596 - 598
  • [23] Sensitization of the myofilaments and its implication for treatment in human heart failure
    Schwinger, RHG
    Brixius, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (15) : 969 - 973
  • [24] Quantitative measurements of HER2 expression and HER2: HER2 dimerization identify subgroups of HER2 positive metastatic breast cancer patients with different probabilities of response to trastuzumab treatment
    Huang, W.
    Lipton, A.
    Leitzel, K.
    Ali, S. M.
    Fuchs, E. M.
    Weidler, J.
    Chappey, C.
    Sperinde, J.
    Tan, Y.
    Jin, X.
    Paquet, A.
    Winston, J.
    Petropoulos, C.
    Kostler, W. J.
    Bates, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S86 - S86
  • [25] HER2 T cell dependent bispecific antibody (HER2-TDB) for treatment of HER2 positive breast cancer
    Junttila, Teemu T.
    Li, Ji
    Johnston, Jennifer
    Hristopoulos, Maria
    Clark, Robyn
    Ellerman, Diego
    Wang, Bu-Er
    Li, Yijin
    Mathieu, Mary
    Li, Guangmin
    Young, Judy
    Luis, Elizabeth
    Phillips, Gail Lewis
    Stefanich, Eric
    Spiess, Cristoph
    Polson, Andrew
    Irving, Bryan
    Scheer, Justin M.
    Junttila, Melissa R.
    Dennis, Mark S.
    Kelley, Robert
    Totpal, Klara
    Ebens, Allen
    CANCER RESEARCH, 2015, 75
  • [26] Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
    Paralta Branco, F.
    Silva, F.
    Andre, S.
    Catarino, A.
    Madureira, R.
    Moreira Pinto, J.
    Godinho, J.
    Simoes, P.
    Freitas, A. C.
    Casa-Nova, M.
    Nave, M.
    Augusto, J.
    Passos-Coelho, J. L.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S94 - S94
  • [27] Treatment of HER2 Positive Advanced Gastric Cancer: Deviations in HER2 Results and Its Impact on Survival
    Haffner, Ivonne
    Schierle, Katrin
    Maier, Dieter
    Geier, Birgitta
    Raimundez, Elba
    Hasenauer, Jan
    Luber, Birgit
    Kretzschmar, Albrecht
    von Weikersthal, Ludwig Fischer
    Ahlborn, Miriam
    Riera, Jorge
    Rau, Beate
    Siegler, Gabriele
    Fuxius, Stefan
    Decker, Thomas
    Wittekind, Christian
    Lordick, Florian
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 65 - 65
  • [28] Objective Measurement of HER2 and Downstream Signaling Targets in Gastric Cancer
    Carvajal-Hausdorf, Daniel
    Schalper, Kurt
    Syrigos, Konstantinos
    Rimm, David
    MODERN PATHOLOGY, 2015, 28 : 151A - 151A
  • [29] Objective Measurement of HER2 and Downstream Signaling Targets in Gastric Cancer
    Carvajal-Hausdorf, Daniel
    Schalper, Kurt
    S'yrigos, Konstantinos
    Rimm, David
    LABORATORY INVESTIGATION, 2015, 95 : 151A - 151A
  • [30] Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
    Wulfkuhle, Julia D.
    Berg, Daniela
    Wolff, Claudia
    Langer, Rupert
    Kai Tran
    Illi, Julie
    Espina, Virginia
    Pierobon, Mariaelena
    Deng, Jianghong
    DeMichele, Angela
    Walch, Axel
    Bronger, Holger
    Becker, Ingrid
    Waldhoer, Christine
    Hoefler, Heinz
    Esserman, Laura
    Liotta, Lance A.
    Becker, Karl-Friedrich
    Petricoin, Emanuel F., III
    CLINICAL CANCER RESEARCH, 2012, 18 (23) : 6426 - 6435
12345